Christopher D. Ozeroff
2016
In 2016, Christopher D. Ozeroff earned a total compensation of $439.3K as Secretary, Senior Vice President and General Counsel at ARCA biopharma, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $54,100 |
|---|---|
| Option Awards | $92,447 |
| Salary | $287,389 |
| Other | $5,381 |
| Total | $439,317 |
Ozeroff received $287.4K in salary, accounting for 65% of the total pay in 2016.
Ozeroff also received $54.1K in non-equity incentive plan, $92.4K in option awards and $5.4K in other compensation.
Rankings
In 2016, Christopher D. Ozeroff's compensation ranked 11,623rd out of 14,075 executives tracked by ExecPay. In other words, Ozeroff earned more than 17.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,623 out of 14,075 | 17th |
Division Manufacturing | 4,535 out of 5,489 | 17th |
Major group Chemicals And Allied Products | 1,619 out of 1,895 | 15th |
Industry group Drugs | 1,309 out of 1,538 | 15th |
Industry In Vitro and In Vivo Diagnostic Substances | 50 out of 65 | 23rd |
Source: SEC filing on April 21, 2017.
Ozeroff's colleagues
We found two more compensation records of executives who worked with Christopher D. Ozeroff at ARCA biopharma in 2016.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019